Please select your view
Dr Tan joined St John of God Pathology in November 2012. She graduated with first class honours degrees in both Medical Science and Medicine from the University of Tasmania. After completing her internship and residency at Royal Perth Hospital, she commenced her Anatomical Pathology Fellowship training in Sydney where she completed rotations at Royal North Shore Hospital, Westmead Hospital and Liverpool Hospital.
Dr Tan has special interests in gynaecological and placental pathology and cytopathology, in particular Fine Needle Aspiration biopsies.
In 2015, Dr Tan joined the St John of God Cancer Research Group and helped establish the Gynaecological Cancer Research Group. Her research team is working on a number of translational projects in gynaecologic oncology and has established a research database incorporating the Western Australian Gynaecological Oncology (WAGO) biobank. The main focus of her current research is clinicopathologic aspects of uterine and ovarian cancers. She has a clinical appointment (Senior Lecturer) with the School of Surgery at the University of Western Australia.
Dr Tan is a member of the gynaecology, cytopathology and HNE subspecialty teams.
Dr Travis Brown obtained his MBBS from the Australian National University (ANU) in Canberra. After completing two years as a junior doctor at St Vincent Hospital in Melbourne, he undertook Anatomical Pathology training at Ballarat Base Hospital and the Royal Melbourne Hospital before transferring to General Pathology Specialty training with Healthscope Pathology (now Australian Clinical Labs) in Clayton, Melbourne. Before studying medicine, Travis completed a Bachelor of Commerce/Bachelor of Computing at the University of Ballarat and worked for two years in the Global Risk Management Services (Information Technology) department with PricewaterhouseCoopers in Melbourne.
He also completed a Bachelor of Science (Medical Sciences) at La Trobe University in Melbourne before entering graduate entry medicine at Canberra. Travis completed General Pathology Specialty training in November 2016 and is currently working in Wayville, Adelaide with Australian Clinical Labs. He enjoys the diversity that General Pathology provides working in biochemistry, microbiology, haematology and anatomical pathology. Travis also has a special interest in Information Technology and Pathology informatics.
Assoc. Prof. Hemmings worked in Auckland, Christchurch and Canberra and undertook sabbatical fellowships in London and Boston. Dr Hemmings has subspecialty expertise in soft tissue, gastrointestinal, and head, neck and endocrine pathology and she has a particular interest in rare cancers including sarcoma, neuroendocrine tumours and GIST, and in tumour biology as it informs the multidisciplinary management of cancer. She belongs to several professional interest groups in these areas, including COSA, AGITG, ASSG, ENETS, ANZNET and the European Society of Pathology. Dr Hemmings serves on the ASSG Scientific Advisory Committee, the WA Colorectal Tumour Collaborative Group and the Clinical Advisory Group of the National Bowel Cancer Screening Programme, and she is a founding member and foundation Secretary/Treasurer of the Australasian Gastrointestinal Pathology Society.
Dr Jayasinghe joined Healthscope Pathology in 2012. Having completed her specialist training and MD in Histopathology in Sri Lanka, Dr Jayasinghe moved to Australia. She trained as an Anatomical Pathology Registrar rotating through Monash Medical Centre and Peter MacCallum Cancer Centre. After obtaining her FRCPA in 2011, Dr Jayasinghe worked as an Anatomical Pathologist at the Royal Women's Hospital, Melbourne before joining Healthscope Pathology at The Northern Hospital. While she enjoys the whole variety of her histopathology and cytopathology work, her special interests are in breast and gynaecological pathology.
Professor O’Toole is recognised as one of Australia’s leading molecular pathologists, with major research and diagnostic interests in breast cancer as well as the molecular pathology of melanoma and lung cancer. She was an expert member of the working group for Cancer Australia on Influencing Best Practice in Breast Cancer and is a National Breast Cancer Foundation Practitioner Fellow.
Professor O’Toole is Clinical Professor at Sydney Medical School and head of Breast Cancer Translational Research at the Garvan Institute of Medical Research where she collaborates with researchers and clinicians nationally and internationally to promote the rapid translation of scientific discoveries. Her work has appeared in more than 100 scientific publications and she has secured over $20 million in research funding as a chief investigator. She is Chair of Cancer Services for the Royal College of Pathologists of Australasia.
Her areas of interest include Molecular Pathology, Breast Pathology and GIT/Hepatobiliary Pathology. She is FRCPA and holds MB, BS (Hons I and the University Medal), BSc Med (Hons I and recipient of the Prize for Experimental Pathology) and a PhD.
Dr Mirette Saad is a Chemical Pathologist and the National Clinical Director of the Molecular Genetic Pathology at Australian Clinical Labs.
Dr Saad’s current professional interests are continuing development in Molecular Genetics and Chemistry. In addition to her daily work to provide a comprehensive Chemical Pathology testing service, she currently medically supervises the Molecular Genetic testing for non-invasive prenatal testing (NIPT), hereditary disorders, personalised drug therapy and cancer. She is working closely with Health Practitioners and the laboratory team to employ the knowledge and identify opportunities to provide the best diagnostic services which include interpretation of results and the provision of important consultative advice to doctors in assisting with the management plans of patients.
Recently our scientists provided critically needed blood, platelets and plasma to three Geelong patients at risk of bleeding to death in the same afternoon. Thank you to our scientists whose expertise and calm in the face of an emergency contributed to the patients pulling through.
From 1 December 2017, the traditional ‘pap’ smear will be replaced by a HPV (Human Papilloma Virus) DNA test which can detect a larger range of the existing 40
Friday 28 July marks the World Health Organization’s (WHO) World Hepatitis Day. According to WHO more than 325 million people world-wide are infected with Hepatitis and WHO is committed to eradicating the disease.
Australian Clinical Labs is excited to announce that it has secured a long term contract to provide pathology services at the new Northern Beaches Hospital in New South Wales.